Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market
Holding RLAY?
Track your performance easily

Relay Therapeutics (RLAY) Ownership - Who Owns Relay Therapeutics?

377 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 31, 2024
xxxxxxxxxxxxx
$14496
Jul 31, 2024
Donald A Bergstrom
President, R&d
xxxxxxxxxxxxx
$23877
Jul 31, 2024
xxxxxxxxxxxxx
$15063
Jul 31, 2024
Peter Rahmer
Chief Corporate Development Officer
xxxxxxxxxxxxx
$12027

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$304497
Jun 30, 2024
xxxxxxxxxxxxx
$315444
Jun 30, 2024
xxxxxxxxxxxxx
$701343
Jun 30, 2024
xxxxxxxxxxxxx
$1783976

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
11,070,428Institution6.81%84,135,253
10,282,812Institution6.33%78,149,371
4,862,351Institution2.99%36,953,868
2,143,870Institution1.32%16,293,412
2,073,166Institution1.28%15,756,062
1,943,097Institution1.20%14,767,537
1,773,894Institution1.09%13,481,594
1,613,462Institution0.99%12,262,311
1,287,830Institution0.79%9,787,508
1,214,260Institution0.75%9,228,376

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
10,282,812Institution6.33%78,149,371
2,073,166Institution1.28%15,756,062
1,773,894Institution1.09%13,481,594
1,613,462Institution0.99%12,262,311
1,287,830Institution0.79%9,787,508
1,214,260Institution0.75%9,228,376
1,058,328Institution0.65%8,043,293
984,136Institution0.61%7,479,434
865,767Institution0.53%6,579,829
859,551Institution0.53%6,532,588

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,869,332Institution2.38%31,805,909
3,178,473Institution1.96%26,127,048
2,632,206Institution1.62%20,004,766
2,012,508Institution1.24%16,321,440
1,778,740Institution1.09%14,621,243
1,465,631Institution0.90%12,047,487
932,286Institution0.57%7,085,374
638,194Institution0.39%4,850,274
464,732Institution0.29%3,768,977
392,932Institution0.24%3,229,901

FAQ

Who Owns Relay Therapeutics (RLAY)?
Currently, no data Available
What percentage of Relay Therapeutics (RLAY) stock is held by institutional investors?
Currently, no data Available
What percentage of Relay Therapeutics (RLAY) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Relay Therapeutics (RLAY)?
Vanguard owns the most shares of Relay Therapeutics (RLAY).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis